Lyell Competitors and Similar CompaniesClear all
NovoCure's competitors and similar companies include Agenus.
 NovoCure NovoCure is a company engaged in the development, manufacture, and commercialization of solutions for the treatment of solid tumors. |  Agenus Agenus is an immuno-oncology company that focuses on the discovery and development of therapies for treating cancer. | |
Founding Date | Founding Date 2000 | Founding Date 1994 |
Type | Type Public | Type Public |
Tags | ||
Locations | Locations Lexington, US HQ Cambridge, GB Emeryville, US Berkeley, US Vacaville, US | |
Employees | Employees 1,488 | Employees 8174% decrease |
Valuation ($) | Valuation ($) 1.8 b | Valuation ($) 96.2 m |
Financial | ||
Revenue (est.) | Revenue (est.) $655.4m (FY, 2025) | Revenue (est.) $114.2m (FY, 2025) |
Cost of goods | Cost of goods $166.9m (FY, 2025) | Cost of goods $1m (FY, 2025) |
Gross profit | Gross profit $488.5m (FY, 2025) | Gross profit $113.2m (FY, 2025) |
Net income | Net income ($136.2m) (FY, 2025) | Net income ($3.1m) (FY, 2025) |
For sources of this data, please see the company profile
View Company Profiles
Agenus
HQ
Lexington, US
Employees
81
Agenus is an immuno-oncology company that focuses on the discovery and development of therapies for treating cancer.
View company